Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Citadel Group M&A Activity 2020

Apr 14, 2020

10454_mrq_2020-04-14_cd872c6b-b14d-4602-8b04-c895c1fbe093.html

M&A Activity

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 5589J

Citadel Group

14 April 2020

Ap 19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.         KEY INFORMATION

Name of person dealing (Note 1)

Citadel Group

Company dealt in

ALLERGAN PLC

Class of relevant security to which the dealings being disclosed relate (Note 2)

Common Stock ISIN IE00BY9D5467

Date of dealing

13 April, 2020

2.         INTERESTS AND SHORT POSITIONS

(a)        Interests and short positions (following dealing) in the class of relevant security

dealt in (Note 3)

Long Short
Common Stock  ISIN  IE00BY9D5467 Number        (%) Number      (%)
(1) Relevant securities 3,441,024 (1.05%) 0 (0.00%)
(2) Derivatives (other than options) 3,465,201 (1.05%) 0 (0.00%)
(3) Options and agreements to purchase/sell 0 (0.00%) 0 (0.00%)
Total 6,906,225(2.10%) 0 (0.00%)

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Long Short
Number        (%) Number      (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap 20

1.         DEALINGS (Note 4)

(a)        Purchases and sales

Purchase/sale

Common Stock ISIN IE00BY9D5467
Number of securities Price per unit (Note 5)
Purchase 100 182.21  USD
Purchase 100 182.39  USD
Purchase 236 182.46885593  USD
Purchase 406 182.52334975  USD
Purchase 350 182.55  USD
Purchase 130 182.80307692  USD
Purchase 300 182.81466667  USD
Purchase 748 182.8273262  USD
Purchase 110 182.85090909  USD
Purchase 585 182.93762393  USD
Purchase 2,086 182.95677852  USD
Purchase 1,399 182.97248034  USD
Purchase 939 183.03110756  USD
Purchase 597 183.04681742  USD
Purchase 300 183.07  USD
Purchase 210 183.10809524  USD
Purchase 383 183.13164491  USD
Purchase 310 183.19903226  USD
Purchase 100 183.48  USD
Purchase 3,617 183.83  USD
Sale -200 182.015  USD
Sale -182 182.26120879  USD
Sale -71 182.29  USD
Sale -653 182.32852986  USD
Sale -100 182.38  USD
Sale -15 182.52  USD
Sale -1,030 182.63834951  USD
Sale -594 182.65597643  USD
Sale -602 182.74960133  USD
Sale -589 182.78040747  USD
Sale -287 182.79700348  USD
Sale -100 182.81  USD
Sale -262 182.84854962  USD
Sale -997 182.84878636  USD
Sale -1,479 182.87613252  USD
Sale -414 182.94975845  USD
Sale -2,986 182.96831045  USD
Sale -508 183.00885827  USD
Sale -252 183.00992064  USD
Sale -1,458 183.02840192  USD
Sale -541 183.13868762  USD
Sale -12 183.48  USD
Sale -120 183.54416667  USD
Sale -10 183.82  USD
Sale -9 183.91  USD
Sale -44 183.92  USD

(b)        Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

 ISIN
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit

(Note 5)

(c)        Options transactions in respect of existing relevant securities

(i)         Writing, selling, purchasing or varying

Product name, e.g. call option Writing, selling, purchasing,

varying etc.
Number of securities to which the option relates (Note 7) Exercise price Type,

e.g. American, European etc.
Expiry date Option money paid/ received per unit

(Note 5)

(ii)        Exercising

Product name,

e.g. call option
Number of securities Exercise price per unit

(Note 5)

(d)        Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)
Details Price per unit

      (if applicable) (Note 5)

Ap 21

2.         OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated
None

Is a Supplemental Form 8 attached? (Note 9)

NO

Date of disclosure: 14 April, 2020
Contact name: Katie Bonds
Telephone number: 020 7645 9700
If a connected EFM, name of offeree/offeror with which connected n/a
If a connected EFM, state nature of connection (Note 10) n/a

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

ISEMZGMDLDNGGZG